Incentive Stock Programs

9 Months Ended

Sep. 30, 2024

Share-Based Payment Arrangement [Abstract]

Note 9 — Incentive Stock Programs

In the first nine months of 2024, Abbott granted 1,683,097 stock options, 404,597 restricted stock awards and 5,308,735 restricted stock units under its incentive stock program. At September 30, 2024, approximately 61 million shares were reserved for future grants. Information regarding the number of options outstanding and exercisable at September 30, 2024 is as follows:


	Outstanding		Exercisable
Number of shares	27,024,268		23,137,620
Weighted average remaining life (years)	4.7		4.1
Weighted average exercise price	$	80.25	$	74.71
Aggregate intrinsic value (in millions)	$	952	$	941

The total unrecognized share-based compensation cost at September 30, 2024 amounted to approximately $567 million, which is expected to be recognized over the next three years.